Retraction: Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction (Restorative Neurology and Neuroscience (2020) 38 (385-393) DOI: 10.3233/RNN-201041);Escitalopram improves neural functional prognosis and endothelial dysfunction in patients with acute cerebral infarction

Restorative Neurology and Neuroscience

Volumn 38, Issue 5, 2020, Pages 385-393

  Cao, Jin Xia ^a   Liu, Li ^a   Sun, Yun Tao ^a   Zeng, Qing Hong ^a   Yang, Zhen Dong ^a   Chen, Jie Chun ^a  

^a Lianyungang Second People's Hospital   (China)

Author keywords

acute ischemic stroke; endothelial dysfunction; Escitalopram

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ATORVASTATIN; CLOPIDOGREL; EDARAVONE; ENOXAPARIN; ESCITALOPRAM; ESCITIDE OXALATE; NIMODIPINE; ROSUVASTATIN; WARFARIN; CITALOPRAM; SEROTONIN UPTAKE INHIBITOR;

ABDOMINAL DISCOMFORT; ACUTE ISCHEMIC STROKE; ANTICOAGULANT THERAPY; BARTHEL INDEX; BASAL GANGLION; BRACHIAL ARTERY; BRAIN FUNCTION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR DISEASE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DRUG WITHDRAWAL; DSM-IV; ELECTROCARDIOGRAM; ENDOTHELIAL DYSFUNCTION; FLOW-MEDIATED DILATION TEST; FOLLOW UP; HAMILTON DEPRESSION RATING SCALE; HUMAN; MAJOR CLINICAL STUDY; MINI MENTAL STATE EXAMINATION; MORNING DOSAGE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGICAL DEFICIT SCORE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN THERAPY; POST-STROKE DEPRESSION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA; ACUTE DISEASE; AGED; BRAIN ISCHEMIA; DIAGNOSTIC IMAGING; DRUG EFFECT; FEMALE; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; AGED; CEREBRAL INFARCTION; CITALOPRAM; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ISCHEMIC STROKE; MALE; MIDDLE AGED; OUTCOME ASSESSMENT, HEALTH CARE; PROGNOSIS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 85096203048     PISSN: 09226028     EISSN: 18783627     Source Type: Journal    
DOI: 10.3233/rnn-201041     Document Type: Erratum

References (34)

1. Chollet, F., Tardy, J., Albucher, J.F., Thalamas, C., Berard, E., Lamy, C., Bejot, Y., Deltour, S., Jaillard, A., Niclot, P., Guillon, B., Moulin, T., Marque, P., Pariente, J., Arnaud, C., amp; Loubinoux, I. (2011). Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): A randomised placebocontrolled trial. The Lancet Neurology, 10(2), 123-130.
2. Chung, J.W., Oh, M.J., Cho, Y.H., Moon, G.J., Kim, G.M., Chung, C.S., Lee, K.H., amp; Bang, O. Y. (2017). Distinct Roles of Endothelial Dysfunction and Inflammation in Intracranial Atherosclerotic Stroke. European Neurology, 77(3-4), 211-219.
3. Cipriani, A., Santilli, C., Furukawa, T.A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., amp; Barbui, C. (2009). Escitalopram versus other antidepressive agents for depression. The Cochrane Database of Systematic Reviews, (2), CD006532.
4. Corretti, M.C., Anderson, T.J., Benjamin, E.J., Celermajer, D., Charbonneau, F., Creager, M.A., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., Vallance, P., Vita, J., Vogel, R., amp; International Brachial Artery Reactivity Task Force (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39(2), 257-265.
5. Cramer, S.C. (2018). Treatments to Promote Neural Repair after Stroke. Journal of Stroke, 20(1), 57-70.
6. Espinera, A.R., Ogle, M.E., Gu, X., Wei, L. (2013). Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice. Neuroscience, 247, 1-11.
7. Etherton, M.R., Siddiqui, K.A., amp; Schwamm, L.H. (2018). Prestroke selective serotonin reuptake inhibitor use and functional outcomes after ischaemic stroke. Stroke and Vascular Neurology, 3(1), 9-16.
8. FOCUS Trial Collaboration (2019). Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): A pragmatic, double-blind, randomised, controlled trial. Lancet (London, England), 393(10168), 265-274.
9. Gu, S.C., amp; Wang, C.D. (2018). Early Selective Serotonin Reuptake Inhibitors for Recovery after Stroke: A Meta-Analysis and Trial Sequential Analysis. Journal of stroke and cerebrovascular diseases : The official journal of National Stroke Association, 27(5), 1178-1189.
10. He, Y.T., Tang, B.S., Cai, Z.L., Zeng, S.L., Jiang, X., amp; Guo, Y. (2016). Effects of Fluoxetine on Neural Functional Prognosis after Ischemic Stroke: A Randomized Controlled Study in China. Journal of Stroke and Cerebrovascular Diseases : The official journal of National Stroke Association, 25(4), 761-770.
11. Kim, J.S., Lee, E.J., Chang, D.I., Park, J.H., Ahn, S.H., Cha, J.K., Heo, J.H., Sohn, S.I., Lee, B.C., Kim, D.E., Kim, H.Y., Kim, S., Kwon, D.Y., Kim, J., Seo,W.K., Lee, J., Park, S.W., Koh, S.H., Kim, J.Y., Choi-Kwon, S., . . . EMOTION investigators (2017). Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: A multicentre, double-blind, randomised, placebo-controlled study. The lancet Psychiatry, 4(1), 33-41.
12. Kim, J., amp; Kim, Y. (2018). Which Patients Are Prescribed Escitalopram?: Predictors for Escitalopram Prescriptions and Functional Outcomes among Patients with Acute Ischemic Stroke. International Journal of Environmental Research and Public Health, 15(6), 1085.
13. Lapergue, B., Blanc, R., Gory, B., Labreuche, J., Duhamel, A., Marnat, G., Saleme, S., Costalat, V., Bracard, S., Desal, H., Mazighi, M., Consoli, A., Piotin, M., amp; ASTER Trial Investigators (2017). Effect of Endovascular Contact Aspiration vs Stent Retriever on Revascularization in Patients With Acute Ischemic Stroke and Large Vessel Occlusion: The ASTER Randomized Clinical Trial. JAMA, 318(5), 443-452.
14. Le Friec, A., Salabert, A.S., Davoust, C., Demain, B., Vieu, C., Vaysse, L., Payoux, P., amp; Loubinoux, I. (2017). Enhancing Plasticity of the Central Nervous System: Drugs, Stem Cell Therapy, and Neuro-Implants. Neural Plasticity, 2017, 2545736.
15. Lee, E.J., Kim, J.S., Chang, D.I., Park, J.H., Ahn, S.H., Cha, J.K., Heo, J.H., Sohn, S.I., Lee, B.C., Kim, D.E., Kim, H.Y., Kim, S., Kwon, D.Y., Kim, J., Seo,W.K., Lee, J., Park, S.W., Koh, S.H., Kim, J.Y., Choi-Kwon, S., . . . EMOTION Investigators (2018). Differences in Therapeutic Responses and Factors Affecting Post-Stroke Depression at a Later Stage According to Baseline Depression. Journal of Stroke, 20(2), 258-267.
16. Li, G., Bao, H., Hao, J.J., Zuo, L., Xiao, Y.P., Yang, Y.M., Wang, Y., Hu, H., Huang DY,Wang, S.S. (2013) Guidelines for early management of patients with acute ischemic stroke-American heart association/American stroke association guidelines for healthcare professionals (part 8). Chinese Journal of Stroke, 8(12), 984-987.
17. Ng, K.L., Gibson, E.M., Hubbard, R., Yang, J., Caffo, B., O?Brien, R.J., Krakauer, J.W., amp; Zeiler, S.R. (2015). Fluoxetine Maintains a State of Heightened Responsiveness to Motor Training Early After Stroke in a Mouse Model. Stroke, 46(10), 2951-2960.
18. Ninomia, T., Wang, L., Kumar, S.R., Kim, A., amp; Zlokovic, B. V. (2000). Brain injury and cerebrovascular fibrin deposition correlate with reduced antithrombotic brain capillary functions in a hypertensive stroke model. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 20(6), 998-1009.
19. Omisore, A.D.,Ayoola, O.O., Ibitoye, B.O., Fawale, M.B.,Adetiloye, V.A. (2017). Sonographic Evaluation of Endothelial Function in Brachial Arteries of Adult Stroke Patients. Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 36(2), 345-351.
20. Onkelinx, S., Cornelissen, V., Goetschalckx, K., Thomaes, T., Verhamme, P., amp; Vanhees, L. (2012). Reproducibility of different methods to measure the endothelial function. Vascular Medicine (London, England), 17(2), 79-84.
21. Pinto, C.B., Saleh Velez, F.G., Lopes, F., de Toledo Piza, P.V., Dipietro, L., Wang, Q.M., Mazwi, N.L., Camargo, E.C., Black-Schaffer, R., amp; Fregni, F. (2017). SSRI and Motor Recovery in Stroke: Reestablishment of Inhibitory Neural Network Tonus. Frontiers in Neuroscience, 11, 637.
22. Pretnar-Oblak, J., Sabovic, M., Sebestjen, M., Pogacnik, T., amp; Zaletel, M. (2006). Influence of atorvastatin treatment on L-Arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. Stroke, 37(10), 2540-2545
23. Pretnar-Oblak, J., Sabovic, M., Vidmar, G., amp; Zaletel, M. (2007). Evaluation of L-Arginine reactivity in comparison with flowmediated dilatation and intima-media thickness. Ultrasound in Medicine & Biology, 33(10), 1546-1551.
24. Robinson, R.G., Jorge, R.E., Moser, D.J., Acion, L., Solodkin, A., Small, S.L., Fonzetti, P., Hegel, M., amp; Arndt, S. (2008). Escitalopram and problem-solving therapy for prevention of poststroke depression: A randomized controlled trial. JAMA, 299(20), 2391-2400.
25. Santos-Garcia, D., Blanco, M., Serena, J., Arias, S., Millan, M., Rodriguez-Yanez, M., Leira, R., Davalos, A., amp; Castillo, J. (2009). Brachial arterial flow mediated dilation in acute ischemic stroke. European Journal of Neurology, 16(6), 684-690.
26. Santos-Garcia, D., Blanco, M., Serena, J., Rodriguez-Yanez, M., Leira, R., amp; Castillo, J. (2011). Impaired brachial flowmediated dilation is a predictor of a new-onset vascular event after stroke. Cerebrovascular Diseases (Basel, Switzerland), 32(2), 155-162.
27. Savadi Oskouie, D., Sharifipour, E., Sadeghi Bazargani, H., Hashemilar, M., Nikanfar, M., Ghazanfari Amlashi, S., Abbaszade, Z., Sadeghihokmabadi, E., Rikhtegar, R., amp; Golzari, S. (2017). Efficacy of Citalopram on Acute Ischemic Stroke Outcome: A Randomized Clinical Trial. Neurorehabilitation and Neural Repair, 31(7), 638-647.
28. Siepmann, T., Kepplinger, J., Zerna, C., Schatz, U., Penzlin, A.I., Pallesen, L.P., Illigens, B.M., Weidner, K., Reichmann, H., Puetz, V., Bodechtel, U., amp; Barlinn, K. (2015). The Effects of Pretreatment versus De Novo Treatment with Selective Serotonin Reuptake Inhibitors on Short-Term Outcome after Acute Ischemic Stroke. Journal of stroke and cerebrovascular diseases : The official journal of National Stroke Association, 24(8), 1886-1892.
29. Taylor, W.D., Aizenstein, H.J., amp; Alexopoulos, G.S. (2013). The vascular depression hypothesis: mechanisms linking vascular disease with depression. Molecular Psychiatry, 18(9), 963-974.
30. Tuttolomondo, A., Casuccio, A., Della Corte, V., Maida, C., Pecoraro, R., Di Raimondo, D., Vassallo, V., Simonetta, I., Arnao, V., amp; Pinto, A. (2017). Endothelial function and arterial stiffness indexes in subjects with acute ischemic stroke: Relationship with TOAST subtype. Atherosclerosis, 256, 94-99.
31. Villa, R.F., Ferrari, F., amp; Moretti, A. (2018). Post-stroke depression: Mechanisms and pharmacological treatment. Pharmacology & Therapeutics, 184, 131-144.
32. Yang, G., Wang, Y., Zeng, Y., Gao, G.F., Liang, X., Zhou, M., Wan, X., Yu, S., Jiang, Y., Naghavi, M., Vos, T., Wang, H., Lopez, A.D., amp; Murray, C.J. (2013). Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet, 381(9882), 1987-2015.
33. Zimmermann, C.,Wimmer,M.,Haberl, R.L. (2004). L-Argininemediated vasoreactivity in patients with a risk of stroke. Cerebrovascular Diseases (Basel, Switzerland), 17(2-3), 128-133.
34. Zvan, B., Zaletel, M., Pogacnik, T., amp; Kiauta, T. (2002). Testing of cerebral endothelium function with L-Arginine after stroke. International angiology : A journal of the International Union of Angiology, 21(3), 256-259